Evidence map›Paper›PMID 39395756›Full record

ArticleJournal of substance use and addiction treatment2025

The Support Hospital Opioid Use Disorder Treatment (SHOUT) Texas program implementation strategy for expanding treatment for hospitalized adults with opioid use disorder.

Christopher Moriates, Alanna Boulton, Richard Bottner, John Weems, Nicholaus Christian, Taylor Bazajou, Daniela I Olmos, Carma Deem Bolton, Tara E Karns-Wright, Holly J Lanham and 2 more

Abstract read
In one paragraph

Article in Journal of substance use and addiction treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christopher MoriatesVeterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America; Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America. Electronic address: Cmoriates@mednet.ucla.edu.
Alanna BoultonDell Medical School at The University of Texas at Austin, Austin, TX, United States of America.
Richard BottnerDell Medical School at The University of Texas at Austin, Austin, TX, United States of America; Colorado Hospital Association, Greenwood Village, CO, United States of America.
John WeemsDell Medical School at The University of Texas at Austin, Austin, TX, United States of America; Addiction Medicine, CommUnityCare, Austin, TX, United States of America.
Nicholaus ChristianOffice of the Clinical Director, National Institute on Drug Abuse, Gaithersburg, MD, United States of America.
Taylor BazajouBe Well Texas, Department of Psychiatry & Behavioral Sciences, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Daniela I OlmosBe Well Texas, Department of Psychiatry & Behavioral Sciences, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Carma Deem BoltonBe Well Texas, Department of Psychiatry & Behavioral Sciences, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Tara E Karns-WrightBe Well Texas, Department of Psychiatry & Behavioral Sciences, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Holly J LanhamThe University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Erin P FinleyVeterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America; The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.
Jennifer S PotterBe Well Texas, Department of Psychiatry & Behavioral Sciences, The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States of America.

Funding

Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

introductionIn 2017, we launched the "B-Team" (buprenorphine team), the first hospitalist-led opioid use disorder (OUD) treatment program in Texas. Based on initial success, we obtained funding from Texas Health & Human Services to expand the model to other hospitals in Texas through the Support Hospital Opioid Use Disorder Treatment (SHOUT) Texas program.

methodsThis is a mixed methods study of the implementation of the SHOUT program, which is an OUD treatment intervention, in different hospitals in Texas. Our implementation approach combined training, tailoring, and technical assistance following the Replicating Effective Programs (REP) strategy with statewide telementoring delivered via Project ECHO. To evaluate the reach, adoption, and impact of SHOUT Texas, we assessed: 1) participating hospitals (adoption); 2) patients screened for OUD (impact); 3) patients started on medications for OUD (impact); 4) patients discharged with coordinated outpatient care (impact); 5) providers and staff trained via ECHO (reach); and 6) satisfaction with ECHO training (impact). Additionally, semi-structured interviews were conducted with key stakeholders at expansion sites to identify strengths and weaknesses of the implementation strategy and supports and barriers to successful implementation. Rapid qualitative analysis was completed by a team of analysts who transcribed and summarized interviews to identify key domains of interest and emergent themes.

resultsBetween 2020 and 2023, the SHOUT Texas program expanded to three additional Texas hospital sites, resulting in 3065 hospitalized adult patients starting treatment for OUD. More than 2500 interprofessional clinicians (physicians, nurses, physician assistants, social workers) received SHOUT training regarding inpatient initiation of OUD treatment, with 241 attending at least one hour-long Project ECHO session. Eight key stakeholders at expansion sites were interviewed. Successful components of the SHOUT program included training resources, in-person launches, and collaboration with specialized addiction treatment subject matter experts. Challenges included identifying outpatient follow-up, pharmacy and medication constraints, and nursing education barriers. Interviews also identified lessons learned, advice to other hospitals, and next steps to build capacity.

conclusionsImplementation of the SHOUT Texas model across diverse hospital settings using REP and Project ECHO resulted in significant provider engagement and rapid increase in the number of patients initiating OUD treatment during hospitalization. Lessons learned from this novel approach may be applicable in other states, particularly those that have not expanded Medicaid.

Indexed as

Opioid-Related DisordersAdultBuprenorphineFemaleHospitalistsHospitalizationHospitalsHumansMaleOpiate Substitution TreatmentProgram EvaluationTexasBuprenorphineAddiction medicineBuprenorphineImplementation scienceMedications for opioid use disorderSubstance use disorder

Identifiers

PMID39395756
PMCPMC11624051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.